PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsDyspnea
MeSH D004417 - dyspnea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012818:Respiratory signs and symptoms
0 Companies
0 Drugs
Success rate
D012120:Respiration disorders
$
Success rate
D004417: 
Dyspnea
$
Success rate
D004418:Paroxysmal dyspnea
$
Success rate
D000092129:Platypnea orthodeoxia syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaMorphine Morphine  2014-12-29   
PadagisMorphine Morphine  2012-08-06   
IngenusMorphine Morphine  2022-02-07   
King PharmaceuticalsMorphine Avinza  2002-03-20   
AlpharmaNaltrexone, Morphine Embeda 2025-07-03 2009-08-13   
AllerganMorphine Kadian  1996-07-03   
Morphine Morphine  1991-09-30   
Rising PharmaceuticalsMorphine Morphine  2011-10-18   
Sun Pharmaceutical IndustriesMorphine Morphine  2012-05-11   
Alkem LaboratoriesMorphine Morphine  2020-12-03   
HospiraMorphine Morphine  1988-05-11   
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
44%
4/9
Phase 2
14%
2/14
Phase 3
25%
3/12
Approved: 1Overall Success rate: 2%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use